Viewing Study NCT02623920


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-04-15 @ 8:36 PM
Study NCT ID: NCT02623920
Status: WITHDRAWN
Last Update Posted: 2017-05-19
First Post: 2015-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor: University of Arizona
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module